Premium
Rapid identification of group B streptococcus carriage by PCR to assist in the management of women with prelabour rupture of membranes in term pregnancy
Author(s) -
Chan Warren S.W.,
Chua Seng C.,
Gidding Heather F.,
Ramjan Don,
Wong May Y.W.,
Olma Tom,
Thomas Lee,
Gilbert Gwendolyn L.
Publication year - 2014
Publication title -
australian and new zealand journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.734
H-Index - 65
eISSN - 1479-828X
pISSN - 0004-8666
DOI - 10.1111/ajo.12145
Subject(s) - medicine , group b , streptococcus , carriage , colonisation , rupture of membranes , prospective cohort study , neonatal infection , pregnancy , obstetrics , gestation , antibiotics , agar , streptococcus agalactiae , cohort , pediatrics , microbiology and biotechnology , biology , bacteria , colonization , genetics , pathology
Background Management of prelabour rupture of membranes at term (37 weeks gestation or later) ( TPROM ) remains complicated in the absence of a rapid assay for group B streptococcus ( GBS ) colonisation. Aims To evaluate the accuracy and clinical utility of a commercial PCR assay, compared with culture, for detection of GBS colonisation in pregnant women presenting with TPROM . Methods A prospective study of women presenting with TPROM conducted in a large tertiary hospital (Westmead Hospital, Australia). Five hundred and seventy‐four consecutive women with TPROM were enrolled between July 2006 and November 2007. Paired low vaginal and anal swabs were collected from women presenting with TPROM for PCR and culture on GBS selective agar following broth enrichment. Primary outcomes were sensitivity and specificity of PCR compared with GBS selective enrichment culture. Secondary analyses included comparison with a historical but otherwise similar cohort regarding clinical utility, maternal and neonatal outcomes. Results PCR sensitivity and specificity were 89.0% (95% CI – 82.8–93.6%) and 97.9% (95% CI – 96.0–99.0%), respectively, compared with culture. 72.3% of women were aware of their GBS PCR status within 3 h of presentation. Compared with the historical cohort, PCR reduced the requirement for intrapartum antibiotics by 25.6% ( P < 0.001). There were no significant differences in maternal outcomes or combined rates of admissions to neonatal intensive care or special care nursery. Conclusions Group B streptococcus PCR is an accurate, rapid, safe and practical alternative to culture for detection of GBS colonisation in pregnant women at the time of TPROM . This method has the potential advantage to reduce costs associated with length of hospital stay.